Market Cap

Oasmia Pharmaceutical AB Market Capitalization:

kr743.2 Million

SEK as of June 1, 2022

US$76.7 Million

business Oasmia Pharmaceutical AB Company Profile

Oasmia Pharmaceutical AB Main Stock Listing

OMX: OASM

Market Capitalization History of Oasmia Pharmaceutical AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Oasmia Pharmaceutical AB market cap

Date Market Cap YoY Change
Jan. 1, 2022 kr1.90 B -46.23%
Jan. 1, 2021 kr3.54 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Oasmia Pharmaceutical AB Categories

Sweden languages Healthcare languages Drug Manufacturers—Specialty & Generic
Sweden Healthcare Sweden Drug Manufacturers—Specialty & Generic

Stocks & Indices

Oasmia Pharmaceutical AB has the following listings and related stock indices.


Stock: OMX: OASM

Stock: OTC: OASMY

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.